 manag metastat breast cancer etoposid extens use malign minor role treatment patient breast cancer single-ag trial etoposid pretreat patient metastat breast cancer low overal respons rate patient evid schedul depend relationship dose intens respons sole single-ag trial untreat patient drug respons rate untreat patient combin therapi trial etoposid cyclophosphamid doxorubicin cisplatin demonstr superior drug singl agent cisplatin etoposid superior agent vitro studi hormone-sensit breast cancer cell estradiol sensit etoposide-induc dna cleavag futur direct use etoposid breast cancer current use etoposid breast cancer investig